MDT - Company ID 0001613103
The table below shows Medtronic plc's income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q2 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|
| Revenue | $9.76B | $9.02B | $8.96B | $8.58B | $8.29B | $8.40B |
| Cost of revenue | $3.42B | $3.26B | $3.06B | $3.00B | $2.78B | $2.95B |
| Gross profit | - | - | - | - | - | - |
| R&D | - | - | - | - | - | - |
Medtronic plc reported annual revenue of $36.36B for fiscal year 2026. That is up 8.4% from $33.54B in fiscal 2025. Over the 10 fiscal years shown, annual revenue grew from $29.71B (FY 2017) to $36.36B. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| SG&A |
| $3.20B |
| $2.96B |
| $2.96B |
| $2.81B |
| $2.72B |
| $2.76B |
| Operating income | $1.76B | $1.46B | $1.69B | $1.45B | $1.65B | $1.59B |
| Income tax | $289.00M | $254.00M | $215.00M | $255.00M | $237.00M | $281.00M |
| Net income | $1.47B | $1.14B | $1.37B | $1.04B | $1.29B | $1.27B |
| EPS (diluted) | $1.14 | $0.89 | $1.07 | $0.81 | $1.01 | $0.99 |